AstraZeneca PLC Files November 2025 6-K Report

TL;DR

AZN filed its monthly 6-K, standard international issuer report, no major news.

AI Summary

AstraZeneca PLC filed a Form 6-K on November 3, 2025, reporting as a foreign issuer. The filing is for the month of November 2025 and indicates the company files annual reports under Form 20-F. AstraZeneca PLC is located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.

Why It Matters

This filing provides routine disclosure for international companies like AstraZeneca, informing investors about their ongoing reporting status and corporate information.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign issuer and does not contain specific financial or operational news that would typically indicate a change in risk.

Key Players & Entities

• AstraZeneca PLC (company) — Filer of the report
• 0001104659-25-105425 (filing_id) — Accession number for the filing
• 20251103 (date) — Filing date and period of report
• 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom (address) — Company's business and mail address
• ZENECA GROUP PLC (company) — Former company name
• 19930422 (date) — Date of name change from ZENECA GROUP PLC

FAQ

From the Filing

0001104659-25-105425.txt : 20251103 0001104659-25-105425.hdr.sgml : 20251103 20251103123637 ACCESSION NUMBER: 0001104659-25-105425 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20251103 FILED AS OF DATE: 20251103 DATE AS OF CHANGE: 20251103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASTRAZENECA PLC CENTRAL INDEX KEY: 0000901832 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11960 FILM NUMBER: 251443042 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE PROVINCE COUNTRY: X0 ZIP: CB2 0AA BUSINESS PHONE: 011 44 20 7304 5000 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE PROVINCE COUNTRY: X0 ZIP: CB2 0AA FORMER COMPANY: FORMER CONFORMED NAME: ZENECA GROUP PLC DATE OF NAME CHANGE: 19930422 6-K 1 tm2529889d1_6k.htm FORM 6-K FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of November 2025 Commission File Number: 001-11960 AstraZeneca PLC 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ¨ No x If “Yes” is marked, indicate below the file number assigned to the Registrant in connection with Rule 12g3-2(b): 82- __________ Exhibit List Exhibit No. Description 99.1 Articles of Association adopted by special resolution passed on 3 November 2025 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ASTRAZENECA PLC Date: November 3, 2025 By: /s/ Matthew Bowden Name: Matthew Bowden Title: Company Secretary EX-99.1 2 tm2529889d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 No. 2723534 THE COMPANIES ACT 2006 PUBLIC COMPANY LIMITED BY SHARES ARTICLES OF ASSOCIATION OF ASTRAZENECA PLC Incorporated 17 June 1992 Registered Office: 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA COMPANY NO. 2723534 COMPANIES ACT 2006 A PUBLIC COMPANY LIMITED BY SHARES ARTICLES OF ASSOCIATION of AstraZeneca PLC (adopted by special resolution passed on 3 November 2025) PRELIMINARY 1. The regulations in Table A in the schedule to the Companies (Tables A to F) Regulations 1985 as in force at the date of the incorporation of the Company shall not apply to the Company. 2. In these Articles, except where the subject or context otherwise requires: Act means the Companies Act 2006 including any modification or re-enactment of it for the time being in force; ADR means an American depositary receipt issued by the ADR Depositary evidencing a number of ADSs; ADR Depositary means JPMorgan Chase Bank, N.A., as depositary for the ADR Programme; ADR Programme means the Company’s ADR programme pursuant to which, as at the date of adoption of these Articles, Ordinary Shares are traded in the United States in the form of ADSs at a ratio of 2:1 ADSs to Ordinary Shares, evidenced by ADRs which are traded o